Mandadi Tilak bought CVS
April 1, 2024 · Form 4 insider transaction
Mandadi Tilak bought 67,920 shares of CVS Health Corporation at $79.56 per share, a transaction worth $5.40M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
67,920
Price
$79.56
Total value
$5.40M
InsiderMandadi Tilak
Role—
CompanyCVS Health Corporation (CVS)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateApril 1, 2024
Filing dateApril 3, 2024
Shares owned after67,920
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option becomes exercisable in four equal annual installments, commencing 4/1/2025.